First clinical trial of an automated blood drawing and testing device
In the future, robots could take blood samples, benefiting patients and healthcare workers alike.
A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
The device provides quick results and would allow healthcare professionals to spend more time treating patients in hospitals and other settings.
The results, published in the journal Technology, were comparable to or exceeded clinical standards, with an overall success rate of 87% for the 31 participants whose blood was drawn. For the 25 people whose veins were easy to access, the success rate was 97%.
The device includes an ultrasound image-guided robot that draws blood from veins. A fully integrated device, which includes a module that handles samples and a centrifuge-based blood analyzer, could be used at bedsides and in ambulances, emergency rooms, clinics, doctors’ offices and hospitals.
Venipuncture, which involves inserting a needle into a vein to get a blood sample or perform IV therapy, is the world’s most common clinical procedure, with more than 1.4 billion performed yearly in the United States. But clinicians fail in 27% of patients without visible veins, 40% of patients without palpable veins and 60% of emaciated patients, according to previous studies.
Repeated failures to start an IV line boost the likelihood of phlebitis, thrombosis and infections, and may require targeting large veins in the body or arteries – at much greater cost and risk. As a result, venipuncture is among the leading causes of injury to patients and clinicians. Moreover, a hard time accessing veins can increase procedure time by up to an hour, requires more staff and costs more than $4 billion a year in the United States, according to estimates.
“A device like ours could help clinicians get blood samples quickly, safely and reliably, preventing unnecessary complications and pain in patients from multiple needle insertion attempts,” said lead author Josh Leipheimer, a biomedical engineering doctoral student in the Yarmush lab in the biomedical engineering department in the School of Engineering at Rutgers University–New Brunswick.
In the future, the device could be used in such procedures as IV catheterization, central venous access, dialysis and placing arterial lines. Next steps include refining the device to improve success rates in patients with difficult veins to access. Data from this study will be used to enhance artificial intelligence in the robot to improve its performance.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Blood-sampling robot
- First Robot-Assisted Dual Kidney Transplant in the US Deemed a Success
Four months out from the actual surgery, the United States' first robot-assisted dual kidney transplant has been ... In 2021, Kukula was diagnosed with multiple myeloma, a form of blood cancer that ...
- 3-D printing artificial blood vessels to improve bypass procedures
A team do researchers at the University of Edinburgh have leveraged 3-D printing technology to create artificial blood cells that strongly resemble human blood cells. This new technology could be used ...
- The safePICO arterial blood gas syringe
With the safePICO self-fill blood gas syringe, you can improve your mixing and get results you can trust. Mixing ball helps you obtain a homogeneous sample SafeTIPCAP minimizes the risk of blood ...
- Engineers create smart valve to boost soft robots’ toughness
Engineers at the University of Sheffield have developed a new type of valve that enhances the resilience of soft robots, making them more durable and reliable. This innovation, reported in Science ...
- Which Surgical Techniques Yield the Best Outcomes for Early Endometrial Cancer?
Researchers compared surgical outcomes among patients with early endometrial cancer who underwent laparoscopic, robotic-assisted, or open surgery.
Go deeper with Google Headlines on:
Blood-sampling robot
[google_news title=”” keyword=”blood-sampling robot” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Automated blood drawing and testing
- New blood test achieves 90% accuracy in diagnosing Alzheimer’s disease, outperforms doctors
Researchers in Sweden developed a combined blood test with up to 90% accuracy for diagnosing Alzheimer's disease, surpassing the diagnostic rates of primary care doctors and specialists.
- Blood Test Shows Promise for Alzheimer’s Diagnosis
A simple blood test shows promise as a way to detect Alzheimer’s disease, which could drastically improve the accuracy and speed of diagnoses.
- Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know
New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday – but some appear to work far better than others. It’s tricky to tell if memory ...
- Alzheimer’s Blood Test Outperforms Standard Diagnostics in New Study
The blood test accurately diagnosed Alzheimer's around 90 percent of the time, compared to 73 percent for specialists and 61 percent for primary care physicians ...
- FDA approves Silicon Valley company’s blood test for colorectal cancer screening among average-risk adults in the US
The maker of the test, Palo Alto-based biotechnology company Guardant Health, announced Monday that this is the first blood test to be approved by the FDA as a primary screening option for ...
Go deeper with Google Headlines on:
Automated blood drawing and testing
[google_news title=”” keyword=”automated blood drawing and testing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]